Global Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market Size, Share, Growth Analysis, By Product & Service (Software & Services, Instruments), By Type of Testing (Laboratory Testing, POC Testing), By Sample Type (Blood, Serum, and Plasma, Urine), By Disease Type (Hepatitis, Mosquito-borne Diseases), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35G2215 | Region: Global | Published Date: September, 2024
Pages: 242 | Tables: 154 | Figures: 77

Infectious Disease Diagnostics Market Insights

Global Infectious Disease Diagnostics Market size was valued at USD 21.20 billion in 2022 and is poised to grow from USD 22.94 billion in 2023 to USD 43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period (2024-2031).

Growing number of elderly people who are prone to infectious diseases, increasing awareness about early diagnosis, high demand for PoC diagnosis due to epidemics, rising infectious diseases are major factors driving the market in the forecast period. 

The growing aging population worldwide and numerous untapped opportunities in developing countries are expected to boost the growth of the industry during the forecast period. According to World Bank Group estimates that in 2022 there were approximately 779 million people aged 65 & older worldwide. In addition, the number of individuals aged 80 and older is expected to more than double in 2050. The rise of infectious diseases is an important driver of rapid income. Moreover, it must be done routine screening of adults to avoid serious infections.  

Increased regulatory scrutiny of the infectious disease diagnostics market as well. The regulatory framework for drug approval has always been one of the major inhibitors in the clinical research industry. The regulatory framework for the research sector is very strict in countries where the market has great potential for growth due to the large patient pool. Such sporadic and uncertain regulatory processes for in vitro diagnostics confuse manufacturers for commercial purposes. 

There are very few direct alternatives to in vitro diagnostics products and services. The use of infectious imaging devices may restrain the market growth to some extent. However, IVD testing for infectious diseases outweighs the risk of alternatives due to its high accuracy and cost.

US Infectious Disease Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Infectious Disease Diagnostics Market size was valued at USD 21.20 billion in 2022 and is poised to grow from USD 22.94 billion in 2023 to USD 43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period (2024-2031).

The competitive scenario of the infectious disease diagnostics market is characterized by established global players, emerging companies and local organizations all contributing to the growth of the industry by innovative a manufacture, partnerships and expansion of strategies. Major manufacturers such as Abbott Laboratories, Roche Diagnostics, Becton, Dickinson & Company (BD), and Biomeriex are market leaders, offering a range of diagnostic solutions from molecular diagnostics to point-of-care testing (POCT). These companies have strengthened their market positions through extensive divisions, strong R&D investments and global distribution networks. 'F. Hoffmann-La Roche Ltd. (Switzerland) ', 'Abbott (US) ', 'bioMérieux (France) ', 'Siemens Healthineers AG (Germany) ', 'Danaher (US) ', 'Thermo Fisher Scientific Inc. (US) ', 'Hologic, Inc. (US) ', 'Becton, Dickinson and Company (US) ', 'Revvity (US) ', 'Qiagen (Netherlands) ', 'Seegene Inc. (South Korea) ', 'QuidelOrtho Corporation (US) ', 'Grifols, S.A. (Spain) ', 'DiaSorin S.p.A. (Italy) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Sysmex Corporation (Japan) ', 'OraSure Technologies (US) ', 'Co-Diagnostics, Inc. (US) ', 'Trinity Biotech (Ireland) ', 'Genetic Signatures Ltd. (Australia) ', 'Epitope Diagnostics, Inc. (US) ', 'Trivitron Healthcare (India) ', 'ELITech Group (France) ', 'Meril Life Sciences Pvt. Ltd. (India) ', 'InBios International, Inc. (US) ', 'Uniogen Oy (Finland) ', 'Vela Diagnostics (Singapore)'

The rise in infectious sicknesses which includes HIV, tuberculosis, hepatitis. COVID-19 is driving the demand for advanced diagnostics globally. These sicknesses require accurate, early diagnosis for powerful treatment, and wearable injectors, incorporated with diagnostic technologies, provide progressive solutions. Additionally, the increasing attention on disorder surveillance and outbreak monitoring has amplified the need for on-hand and speedy diagnostics, assisting marketplace expansion. 

Increase in Point-of-Care Testing (POCT): A major trend in the infectious disease diagnostics market is the rise of POCT. Changes in the decentralization of health care delivery and rapid on-demand analysis have led to the adoption of easy-to-use portable diagnostic kits. This trend does not appear to give rise to not only increases patient attendance but also reduces stress on hospitals by allowing outpatient testing. 

North America region in the infectious disease diagnostics market accounted for 38.49% of the global market in 2023. The industry is expected to keep expanding at lucrative growth during the forecast period with favorable & flexible regulatory framework. Presence of major manufacturers offering new IVD products, more testing and focus on disease management are the major factors driving the North America region. For example, in August 2023, the FDA provided a BD Vaginal Panel in the BD COR program to identify infectious agents that cause vaginal infections. The market for infectious diseases in the United States is expected to grow during the forecast period. The outbreak of COVID-19 dramatically changed the market landscape of diagnostics as companies engaged in test development with faster and more efficient turnaround times.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Infectious Disease Diagnostics Market

Report ID: SQMIG35G2215

$5,300
BUY NOW GET FREE SAMPLE